Next Article in Journal
Antiphytoviral Activity of Satureja montana L. ssp. variegata (Host) P. W. Ball Essential Oil and Phenol Compounds on CMV and TMV
Next Article in Special Issue
Nutraceutical Antioxidants as Novel Neuroprotective Agents
Previous Article in Journal
The Antigerminative Activity of Twenty-Seven Monoterpenes
Previous Article in Special Issue
Pre-Ischemic Treadmill Training Induces Tolerance to Brain Ischemia: Involvement of Glutamate and ERK1/2
Open AccessArticle

Modulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain

1
Deptment of Neurology, University of Göttingen, Robert-Koch Str. 40 37075 Göttingen, Germany
2
DFG-Research Center for Molecular Physiology of the Brain (CMPB), Humboldtallee 23, 37075 Göttingen, Germany
3
Merz Pharmaceuticals, R&D CNS, In vitro Pharmacology, Eckenheimer Landstrasse 100, 60318 Frankfurt, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2010, 15(10), 6678-6687; https://doi.org/10.3390/molecules15106678
Received: 11 August 2010 / Revised: 16 September 2010 / Accepted: 19 September 2010 / Published: 28 September 2010
(This article belongs to the Special Issue Neuroprotective Strategies)
Huntington´s disease, one of the so-called poly-glutamine diseases, is a dominantly inherited movement disorder characterized by formation of cytosolic and nuclear inclusion bodies and progressive neurodegeneration. Recently, we have shown that Bcl-2-associated athanogene-1 (BAG1), a multifunctional co-chaperone, modulates toxicity, aggregation, degradation and subcellular distribution in vitro and in vivo of the disease-specific mutant huntingtin protein. Aiming at future small molecule-based therapeutical approaches, we further analysed structural demands for these effects employing the C-terminal deletion mutant BAGDC. We show that disruption of the BAG domain known to eliminate intracellular heat shock protein 70 (Hsp70) binding and activation also precludes binding of Siah-1 thereby leaving nuclear huntingtin translocation unaffected. At the same time BAGDC fails to induce increased proteasomal huntingtin turnover and does not inhibit intracellular huntingtin aggregation, a pre-requisite necessary for prevention of huntingtin toxicity. View Full-Text
Keywords: BAG1; Huntington’s disease; Chaperone system; Siah1 BAG1; Huntington’s disease; Chaperone system; Siah1
Show Figures

Graphical abstract

MDPI and ACS Style

Liman, J.; Sroka, K.; Dohm, C.P.; Deeg, S.; Bähr, M.; Kermer, P. Modulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain. Molecules 2010, 15, 6678-6687. https://doi.org/10.3390/molecules15106678

AMA Style

Liman J, Sroka K, Dohm CP, Deeg S, Bähr M, Kermer P. Modulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain. Molecules. 2010; 15(10):6678-6687. https://doi.org/10.3390/molecules15106678

Chicago/Turabian Style

Liman, Jan; Sroka, Kamila; Dohm, Christoph P.; Deeg, Sebastian; Bähr, Mathias; Kermer, Pawel. 2010. "Modulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain" Molecules 15, no. 10: 6678-6687. https://doi.org/10.3390/molecules15106678

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop